Market Cap (In INR)
1058.48 Billion
Revenue (In INR)
106.05 Billion
Net Income (In INR)
16.56 Billion
Avg. Volume
6258.00
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2115.95-3589.95
- PE
- 56.83
- EPS
- 55.03
- Beta Value
- 0.258
- ISIN
- INE685A01028
- CUSIP
- -
- CIK
- -
- Shares
- 337404369.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Samir Uttamlal Mehta B.Com., MBA
- Employee Count
- -
- Website
- https://www.torrentpharma.com
- Ipo Date
- 2000-01-03
- Details
- Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.
More Stocks
-
DUB
-
603380
-
2102
-
603912
-
EVGOEVgo, Inc.
EVGO
-
605289
-
9958
-
600515